KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) Cost of Revenue (2018 - 2025)

Historic Cost of Revenue for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $240.5 million.

  • Progyny's Cost of Revenue rose 577.44% to $240.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $977.7 million, marking a year-over-year increase of 961.41%. This contributed to the annual value of $913.9 million for FY2024, which is 753.81% up from last year.
  • Per Progyny's latest filing, its Cost of Revenue stood at $240.5 million for Q3 2025, which was up 577.44% from $253.9 million recorded in Q2 2025.
  • In the past 5 years, Progyny's Cost of Revenue registered a high of $253.9 million during Q2 2025, and its lowest value of $93.2 million during Q1 2021.
  • Over the past 5 years, Progyny's median Cost of Revenue value was $213.0 million (recorded in 2023), while the average stood at $185.0 million.
  • Per our database at Business Quant, Progyny's Cost of Revenue soared by 8809.12% in 2021 and then skyrocketed by 417.56% in 2024.
  • Progyny's Cost of Revenue (Quarter) stood at $102.4 million in 2021, then surged by 65.79% to $169.8 million in 2022, then increased by 25.45% to $213.0 million in 2023, then grew by 10.3% to $235.0 million in 2024, then grew by 2.35% to $240.5 million in 2025.
  • Its Cost of Revenue stands at $240.5 million for Q3 2025, versus $253.9 million for Q2 2025 and $248.2 million for Q1 2025.